OPPORTUNITY SCREENING / M&A ADVISORY
120
OVER
YEARS
At iWisdom, we specialize in identifying and executing strategic investments, empowering businesses to maximize value through tailored M&A advisory services. Our data-driven approach ensures that every opportunity aligns with your company's goals for optimal growth.
OUR PRODUCTS
Opportunity
Screening
Finding, prioritizing and executing strategic investments
FINDING, PRIORITIZING AND EXECUTING STRATEGIC INVESTMENTS
Finding and prioritizing opportunities through in-depth market studies, congresses, and investment analysis for a company’s M&A strategy or a VC fund. Seizing these opportunities by deal structuring, pre- and post-acquisition strategy.
STAKEHOLDERS
OPERATIONAL
MANAGEMENT
APPROACH
• Attending global congresses and analyzing recent deals to identify high-potential investment opportunities.
• Gathering industry knowledge, market research, and investor feedback to align opportunities with the client’s strategic goals.
• Providing in-depth assets' valuation.
• Providing strategic recommendations on whether to proceed with an acquisition after conducting thorough buy-side due diligence on target assets.
• Supporting clients with pre-merger planning, deal structuring, and post-merger integration.
KEY OUTCOMES
• Acquisitions aligned with client strategy.
•“Acquire” or “Don’t acquire” decision-making.
• Maximized returns with minimal risk.
SOLUTIONS
• Data-driven solutions focused on clinical/preclinical results, technology potential, management team assessment, and company operations, among other critical data points.
• In-depth due diligence is presented before any asset acquisition decision.
• Clear “acquire/don’t acquire” recommendations, with revenue forecasts or return on investment clearly defined.
OPTIMAL VALUE EXTRACTION
Expanding strategic portfolios through M&A strategies, with high potential ROI for investment firms.
OPERATIONAL OPTIMIZATION
Ensuring companies have the right structure in place to deliver optimal outcomes post-acquisition.
RISK MANAGEMENT
Providing clear insights into clinical, access, and regulatory risks to ensure the asset reaches the market. Synergy between buyer and seller is also clearly established.